PacBio and 10x Genomics Partnership
PacBio, a prominent player in the field of genomic sequencing, has recently made headlines with a significant development in their collaboration with 10x Genomics. This alliance feature the Onso short-read sequencing instrument, now recognized within the 10x Genomics Compatible Partner Program. This program is designed to facilitate researchers by integrating reliable instruments and workflows compatible with the innovative tools offered by 10x Genomics.
Overview of the Onso Platform
The Onso platform is engineered for high accuracy and performance in short-read sequencing tasks, making it an ideal addition to 10x Genomics’ robust lineup of products aimed at advancing single-cell and spatial biology studies. By joining with 10x Genomics, PacBio enhances the capabilities of scientists striving to decode complex biological systems and further research in various health-related fields.
Key Advantages of the Partnership
With this partnership, researchers can expect to enjoy numerous benefits that enhance their genomic studies:
Streamlined Data Workflows
By combining the capabilities of the Onso platform with those of 10x Genomics, scientists can now access more seamless and efficient end-to-end workflows. This integration promises improved data quality, which is crucial for accurate analysis in genomic research.
Advanced Research Applications
The Onso platform has been designed to seamlessly work with 10x Genomics' Single Cell 3' v3.1 assay. This compatibility opens the door for more extensive applications and insights within the research community.
Leading Accuracy and Precision
Known for delivering exceptional sequencing accuracy, the Onso platform bolsters the effectiveness of 10x Genomics' research tools. This combination reinforces the potential for groundbreaking discoveries in various biological research areas.
Comments from Company Leaders
David Miller, the Vice President of Global Marketing at PacBio, expressed enthusiasm regarding this partnership. "We are excited to expand our partnership with 10x Genomics, an established leader in single-cell and spatial biology solutions. The integration of our Onso short-read sequencing instrument into their partner program signifies a major step forward for researchers looking for high-performance sequencing with superior accuracy,” he remarked. Miller emphasized that this collaboration is set to unfold new avenues for discoveries in complex biological systems.
Furthermore, Rena Bradham, Vice President and Global Head of Marketing at 10x Genomics, welcomed the Onso platform into the program, noting its innovative role in enhancing the understanding of genomic science alongside 10x's advanced tools.
About Pacific Biosciences
PacBio (NASDAQ: PACB) stands out as a life science technology organization dedicated to creating advanced sequencing solutions. Their primary goal is to assist scientists and clinical researchers in solving genetically complex problems. The company's dual-core technologies focus on high quality and accuracy, including HiFi long-read sequencing and short-read sequencing technologies. PacBio’s expansive range of applications extends to human germline sequencing, plant and animal sciences, infectious disease research, oncology, and more.
About 10x Genomics
10x Genomics focuses on developing life science technology, building products that accelerate biological understanding and human health. Their state-of-the-art integrated solutions encompass instruments and software tailored for single-cell and spatial biology, facilitating significant breakthroughs in various fields, including oncology and immunology.
Frequently Asked Questions
What is the Onso short-read sequencing platform?
The Onso platform is a high-performance genomic sequencing tool designed for short-read sequencing, known for its exceptional accuracy.
How does the partnership benefit researchers?
The partnership allows for streamlined workflows and enhanced data quality by integrating PacBio’s Onso platform with technologies from 10x Genomics.
What applications can use the Onso platform?
The Onso platform is compatible with 10x Genomics’ Single Cell 3’ v3.1 assay, extending its applications in various research areas.
Who are the key stakeholders in this collaboration?
PacBio and 10x Genomics are the main stakeholders, with their respective leaders expressing strong support for the collaboration benefits.
What are the primary technologies of PacBio?
PacBio specializes in long-read sequencing and short-read sequencing technologies aimed at addressing complex genetic challenges.
